A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A 26-WEEK STUDY COMPARING THE EFFICACY AND SAFETY OF ONCE-WEEKLY INSULIN ICODEC AND ONCE-DAILY INSULIN GLARGINE U100, BOTH IN COMBINATION WITH INSULIN ASPART, IN ADULTS WITH TYPE 1 DIABETES

Intervention/treatment:
INSULIN ICODEC
Medical condition:
TYPE 1 DIABETES
Protocol code:
NN1436-8182
Control number:
296761
Status:
Recruiting
Approved:
May 29, 2025
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT07076199
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Novo Nordisk
Role
CONTACT
Phone:
(+1) 866-867-7178
Sponsor
NOVO NORDISK CANADA INC

Locations

Alberta

Centricity Research Calgary Endocrinology
Calgary, Alberta, T2H 2G4
RECRUITING
University of Calgary
Calgary, Alberta, T2T 5C7
COMPLETED

British Columbia

Vancouver General Hospital_Vancouver_0
Vancouver, British Columbia, V5Z 1M9
RECRUITING

Manitoba

Winnipeg Clinic
Winnipeg, Manitoba, R3C 0N2
RECRUITING

Nova Scotia

Nova Scotia Health Authority
Halifax, Nova Scotia, B3H 2Y9
RECRUITING

Ontario

Centricity Research Brampton Endocrinology
Brampton, Ontario, L6S 0C6
RECRUITING
Centricity Research Etobicoke Endocrinology
Etobicoke, Ontario, M9R 4E1
RECRUITING
Centricity Research LMC (Toronto)
Toronto, Ontario, M9W 4L6
COMPLETED
Centricity Research Toronto LMC Multispec
Toronto, Ontario, M4G 3E8
RECRUITING
Premier Clinical Trial Research Network (PCTRN)
Hamilton, Ontario, L8M 1K7
RECRUITING
Western University Centre for Studies in Fam Med
London, Ontario, N6G 2M1
RECRUITING

Quebec

Centre de Médecine Métabolique de Lanaudière
Terrebonne, Quebec, J6X 4P7
RECRUITING
Centre de Médecine Métabolique de Lanaudière
Terrebonne, Quebec, J6X 4P7
NOT_YET_RECRUITING
Centricity Research Mirabel
Mirabel, Quebec, J7J 2K8
RECRUITING
Clinique des Maladies Lipidiques de Quebec Inc.
Québec, Quebec, G1V 4W2
RECRUITING
Clinique Endocrinologie OASIS.
Montreal, Quebec, H4J 1E3
COMPLETED
Ctr de rech Clin de Laval
Laval, Quebec, H7T 2P5
WITHDRAWN
Ctr de recherche Clinique de Laval
Laval, Quebec, H7T 2P5
COMPLETED
McGill University Health Centre
Montreal, Quebec, H4A 3J1
NOT_YET_RECRUITING
Did you find what you were looking for?